Zolmax

Extreme Networks (NASDAQ:EXTR) Shares Gap Up – Should You Buy?

Posted by Tammy Falkenburg on Nov 6th, 2026

Extreme Networks, Inc. (NASDAQ:EXTR – Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $21.05, but opened at $24.04. Extreme Networks shares last traded at $24.7370, with a volume of 1,300,638... More »

Unity Software (NYSE:U) Price Target Raised to $70.00

Posted by Tammy Falkenburg on Nov 6th, 2026

Unity Software (NYSE:U – Get Free Report) had its price objective raised by investment analysts at Citizens Jmp from $45.00 to $70.00 in a research note issued on Friday, Benzinga reports. The firm currently has a “market... More »

Financial Review: Coincheck Group (NASDAQ:CNCK) versus BitMine Immersion Technologies (NYSE:BMNR)

Posted by Stuart Ham on Nov 6th, 2026

BitMine Immersion Technologies (NYSE:BMNR – Get Free Report) and Coincheck Group (NASDAQ:CNCK – Get Free Report) are both finance companies, but which is the better stock? We will compare the two companies based on the... More »

Halozyme Therapeutics (NASDAQ:HALO) Posts Earnings Results, Beats Expectations By $0.09 EPS

Posted by Alphonse Anthony on Nov 6th, 2026

Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) released its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.39 earnings per share (EPS) for the quarter, beating analysts’ consensus... More »

Intercorp Financial Services (NYSE:IFS) vs. Peoples Financial Services (NASDAQ:PFIS) Head to Head Review

Posted by Alphonse Anthony on Nov 6th, 2026

Intercorp Financial Services (NYSE:IFS – Get Free Report) and Peoples Financial Services (NASDAQ:PFIS – Get Free Report) are both finance companies, but which is the better investment? We will contrast the two companies... More »

Omron (OMRNY) and Its Peers Head to Head Review

Posted by Alphonse Anthony on Nov 6th, 2026

Omron (OTCMKTS:OMRNY – Get Free Report) is one of 377 public companies in the “Electronic Equipment, Instruments & Components” industry, but how does it weigh in compared to its competitors? We will compare Omron... More »

Martin Marietta Materials (NYSE:MLM) Announces Earnings Results

Posted by Wayne Rhoads on Nov 6th, 2026

Martin Marietta Materials (NYSE:MLM – Get Free Report) announced its quarterly earnings data on Wednesday. The construction company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.99 by ($0.52), FiscalAI... More »

MBIA (NYSE:MBI) Announces Earnings Results

Posted by Stuart Ham on Nov 6th, 2026

MBIA (NYSE:MBI – Get Free Report) released its quarterly earnings results on Wednesday. The insurance provider reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.04, FiscalAI... More »

Barclays Issues Positive Forecast for Insulet (NASDAQ:PODD) Stock Price

Posted by Stuart Ham on Nov 6th, 2026

Insulet (NASDAQ:PODD – Get Free Report) had its price objective upped by Barclays from $150.00 to $165.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “equal weight” rating... More »

MGIC Investment (NYSE:MTG) Given New $30.00 Price Target at Barclays

Posted by Wayne Rhoads on Nov 6th, 2026

MGIC Investment (NYSE:MTG – Get Free Report) had its target price increased by stock analysts at Barclays from $29.00 to $30.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an “equal... More »

Neuronetics (NASDAQ:STIM) Stock Gets Price Target Increase from B. Riley Financial

Posted by Wayne Rhoads on Nov 6th, 2026

Neuronetics (NASDAQ:STIM – Get Free Report) had its price objective boosted by investment analysts at B. Riley Financial from $5.00 to $6.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “buy”... More »

Affirm (NASDAQ:AFRM) Given New $100.00 Price Target at Barclays

Posted by Tammy Falkenburg on Nov 6th, 2026

Affirm (NASDAQ:AFRM – Get Free Report) had its target price lowered by investment analysts at Barclays from $105.00 to $100.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently... More »

Barclays Issues Positive Forecast for Janux Therapeutics (NASDAQ:JANX) Stock Price

Posted by Stuart Ham on Nov 6th, 2026

Janux Therapeutics (NASDAQ:JANX – Get Free Report) had its price target increased by Barclays from $14.00 to $15.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an “underweight”... More »

Consolidated Edison (NYSE:ED) Price Target Raised to $108.00

Posted by Wayne Rhoads on Nov 6th, 2026

Consolidated Edison (NYSE:ED – Get Free Report) had its price objective boosted by equities researchers at Barclays from $106.00 to $108.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently... More »

B. Riley Financial Has Lowered Expectations for TripAdvisor (NASDAQ:TRIP) Stock Price

Posted by Stuart Ham on Nov 6th, 2026

TripAdvisor (NASDAQ:TRIP – Get Free Report) had its target price lowered by investment analysts at B. Riley Financial from $12.50 to $8.50 in a research note issued on Friday, Benzinga reports. The firm currently has a “neutral”... More »

The Latest Headlines at Zolmax